Yuan Xiao Zhu

Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi et al. · Blood · 2011 · 591 citations · Full text

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi et al. · Blood · 2014 · 210 citations · Full text

Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo

Rodger E. Tiedemann, Jessica Schmidt, Jonathan J. Keats et al. · Blood · 2008 · 111 citations · Full text

The clinical significance of cereblon expression in multiple myeloma

Steven R. Schuster, K. Martin Kortuem, Yuan Xiao Zhu et al. · Leukemia Research · 2013 · 107 citations · Full text

Hematological Malignancy, Tumor Biology, Medicine +5

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Yuan Xiao Zhu, Rodger E. Tiedemann, Chang-Xin Shi et al. · Blood · 2011 · 105 citations · Full text